Laboratory techniques

$600+ Million Automotive Engine Air Filter Markets - Global Outlook Report 2019-2027 - ResearchAndMarkets.com

Friday, January 15, 2021 - 12:58pm

The "Automotive Engine Air Filter - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Automotive Engine Air Filter - Global Market Outlook (2019-2027)" report has been added to ResearchAndMarkets.com's offering.
  • Global Automotive Engine Air Filter market accounted for $445.20 million in 2019 and is expected to reach $618.72 million by 2027 growing at a CAGR of 4.2% during the forecast period.
  • Automotive engine air filter are used to prevent dirt, dust, and other environmental contaminants from getting into the engine.
  • There are different types of engine air filter available in the market which includes gauze filter, paper/cellulose filter, and many others.

Eurofins launches new tests and massive capacity for detecting and monitoring new variants of SARS-CoV-2

Friday, January 15, 2021 - 6:30am

Currently, strains of concern include the B.1.1.7 variant, first identified in the United Kingdom, and the B.1.351 variant, first identified in South Africa.

Key Points: 
  • Currently, strains of concern include the B.1.1.7 variant, first identified in the United Kingdom, and the B.1.351 variant, first identified in South Africa.
  • Furthermore, this RT-PCR test maintains very high sensitivity in the detection of variants such as B.1.1.7 and B.1.351.
  • Eurofins ability to produce and distribute primers and probes, and commercial PCR kits, additionally benefits the speed of development of new assays.
  • With over 50,000 staff across a network of more than 800 laboratories in over 50 countries, Eurofins companies offer a portfolio of over 200,000 analytical methods.

New Monthly Series Spotlights What 100 Physicians Find to be Critical Needs in Their Battle Against COVID-19

Thursday, January 14, 2021 - 2:15pm

In its first installment of 100 Physicians Find, the Company reports results identifying gaps in the testing toolbox.

Key Points: 
  • In its first installment of 100 Physicians Find, the Company reports results identifying gaps in the testing toolbox.
  • Oxford Immunotec is sharing the results as a call for the industry to heed the need of physicians who are making critical decisions for the wellbeing of patients every day.
  • The data show the majority of physicians (82%) trust the molecular (PCR) test used to confirm an active SARS-CoV-2 infection.
  • Investors should not place undue reliance on forward-looking statements contained herein, which speak only as of the date of this release.

Global Cell Analysis Market (2020 to 2027) - Featuring Danaher, Illumina & Merck Among Others - ResearchAndMarkets.com

Thursday, January 14, 2021 - 1:43pm

The "Cell Analysis Global Market - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cell Analysis Global Market - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
  • The cell analysis global market is expected to reach $33,542.0 million by 2027 growing at a mid-single-digit CAGR from 2020 to 2027.
  • The market for cell analysis is segmented based on technique, product, application, end-user and geography.
  • The cell analysis techniques global market is segmented into PCR, Sequencing, Microfluidics and Microarrays, Spectrometry, Microscopy, Cytometry, High Content Analysis, Electrophoresis and Others.

Twist Bioscience Begins Shipping of Synthetic RNA Controls for UK Variant Strain of SARS-CoV-2

Thursday, January 14, 2021 - 1:00pm

Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has started shipping its new synthetic RNA reference controls, which includes the new variant strain of SARS-CoV-2 identified in the United Kingdom.

Key Points: 
  • Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has started shipping its new synthetic RNA reference controls, which includes the new variant strain of SARS-CoV-2 identified in the United Kingdom.
  • In March, Twist launched synthetic SARS-CoV-2 RNA distinct reference sequences as positive controls for the development of both next-generation sequencing (NGS) and reverse transcription-polymerase chain reaction (RT-PCR) assays to test for SARS-CoV-2.
  • The Twist synthetic controls are designed based on specific SARS-CoV-2 variants, cover the full viral genome and are sequence-verified.
  • Customers purchasing synthetic controls are subject to Twists leading biosecurity screening protocols and applicable laws and regulations.

PerkinElmer SARS-CoV-2 RT-PCR Assay Receives FDA EUA for Asymptomatic Testing

Thursday, January 14, 2021 - 1:00pm

For asymptomatic carriers, diagnostic testing is essential to identify infected individuals, and thereby provides a better chance of getting infectious individuals into isolation to avoid spreading the disease further.

Key Points: 
  • For asymptomatic carriers, diagnostic testing is essential to identify infected individuals, and thereby provides a better chance of getting infectious individuals into isolation to avoid spreading the disease further.
  • Moreover, based on comparative data released by the FDA , the PerkinElmer test kit has the lowest Limit of Detection (LoD) among the authorized COVID-19 molecular diagnostic tests reported, deeming it the most sensitive assay.
  • PerkinElmers RT-PCR assay originally obtained FDA EUA in the spring of 2020.
  • Previously, the FDA issued EUA to allow sample pooling with the PerkinElmer New Coronavirus Nucleic Acid Detection Kit to increase the number of individuals who can be tested without increasing resources.

Seegene's COVID-19 test with saliva sample collection feature now available in Europe

Thursday, January 14, 2021 - 4:24am

With the newly added feature, the saliva sample collection test can be used interchangeably with the nasopharyngeal specimen collection test, normally used for multiplex real-time PCR tests for screening the novel coronavirus.

Key Points: 
  • With the newly added feature, the saliva sample collection test can be used interchangeably with the nasopharyngeal specimen collection test, normally used for multiplex real-time PCR tests for screening the novel coronavirus.
  • Korea's leading molecular diagnostics firm said its saliva sample collection test provides an additional option for the easy, safe and convenient sample gathering without having to compromise sensitivity and specificity of the test.
  • Seegene's saliva sample collection feature can also eliminate the need for materials and labor associated with nucleic acid extraction, as the test is being performed directly from the raw saliva collected from participants.
  • An official from Seegene said the saliva sample collection feature, together with the extraction-free application, also CE-IVD marked in December, will enable labs to carry out massive testing.

Nanofiber Technology Looks Promising for Nonwovens in Filtration Applications

Wednesday, January 13, 2021 - 10:15pm

CLEVELAND, Jan. 13, 2021 /PRNewswire/ -- Demand for nonwovens used in filtration applications is projected to climb 2.7% annually to $1.5 billion in 2024.

Key Points: 
  • CLEVELAND, Jan. 13, 2021 /PRNewswire/ -- Demand for nonwovens used in filtration applications is projected to climb 2.7% annually to $1.5 billion in 2024.
  • For example, in 2019 Verdex Technologies introduced a technology for spinning nanofibers using low-pressure air and no solvents.
  • The technology provides nonwovens producers with the ability to offer a wide variety of functional enhancements to their products, particularly high-efficiency air filtration and liquid cartridge filtration products.
  • While gains in key manufacturing sectors will support growth through 2024, gains will be limited in others due to the COVID-19 pandemic.

Applied DNA Announces Closing of $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Wednesday, January 13, 2021 - 4:44pm

Applied DNA Sciences, Inc. (NASDAQ: APDN) (the Company), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today the closing of its previously announced registered direct offering with a group of institutional investors of 1,810,000 shares of common stock at a price of $8.30 per share, priced at-the-market under Nasdaq rules, resulting in total gross proceeds of approximately $15 million, before deducting the placement agents fees and other estimated offering expenses.

Key Points: 
  • Applied DNA Sciences, Inc. (NASDAQ: APDN) (the Company), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today the closing of its previously announced registered direct offering with a group of institutional investors of 1,810,000 shares of common stock at a price of $8.30 per share, priced at-the-market under Nasdaq rules, resulting in total gross proceeds of approximately $15 million, before deducting the placement agents fees and other estimated offering expenses.
  • The offering was made pursuant to a shelf registration statement on Form S-3 (File No.
  • Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping, and pre-clinical nucleic acid-based therapeutic drug candidates.
  • Applied DNA is a member of the Russell Microcap Index.

Benchmark Drills New Discovery Yielding 101 Metres of 0.82 g/t Gold Equivalent, Including 2 Metres of 14.52 g/t Gold Equivalent

Wednesday, January 13, 2021 - 2:15pm

Drill targeting at the Marmot zone was initiated following systematic geological work that indicates a highly prospective region measuring 2 by 3 kilometres.

Key Points: 
  • Drill targeting at the Marmot zone was initiated following systematic geological work that indicates a highly prospective region measuring 2 by 3 kilometres.
  • The Target has not been evaluated for reasonable prospects for future economic extraction as metallurgical work and drilling are planned and ongoing.
  • Gold was assayed using a fire assay with atomic emission spectrometry and gravimetric finish when required (+10 g/t Au).
  • Benchmark is managed by proven resource sector professionals, who have a track record of advancing exploration projects from grassroots scenarios through to production.